Diabetes cognitive impairments and the effect of traditional Chinese herbs

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Xu, Xiaohan ^a   Guo, Leilei ^a   Tian, Guoqing ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893788723     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/649396     Document Type: Review

References (108)

1. Yang W., Lu J., Weng J., Prevalence of diabetes among men and women in China. New England Journal of Medicine 2010 362 25 2425 2-s2.0-77953956398 10.1056/NEJMc1004671
2. Zhao Y., Ye W., Boye K. S., Holcombe J. H., Hall J. A., Swindle R., Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy. Journal of Diabetes and Its Complications 2010 24 1 9 19 2-s2.0-70749155914 10.1016/j.jdiacomp.2008.09.001
3. Schoenle E. J., Schoenle D., Molinari L., Largo R. H., Impaired intellectual development in children with type I diabetes: association with hba1c, age at diagnosis and sex. Diabetologia 2002 45 1 108 114 2-s2.0-0036160510 10.1007/s125-002-8250-6 (Pubitemid 34118548)
4. Ferguson S. C., Blane A., Perros P., McCrimmon R. J., Best J. J. K., Wardlaw J., Deary I. J., Frier B. M., Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 2003 52 1 149 156 2-s2.0-0037219230 10.2337/diabetes.52.1.149 (Pubitemid 36042120)
5. Brands A. M. A., Van Den Berg E., Manschot S. M., Biessels G. J., Kappelle L. J., De Haan Edward H. E. H. F., Kessels R. P. C., A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus. Journal of the International Neuropsychological Society 2007 13 2 288 297 2-s2.0-33947695732 10.1017/S1355617707070312 (Pubitemid 46499167)
6. Wahlin Å., Nilsson E., Fastbom J., Cognitive performance in very old diabetic persons: the impact of semantic structure, preclinical dementia, and impending death. Neuropsychology 2002 16 2 208 216 2-s2.0-0036209853 10.1037//0894-4105.16.2.208 (Pubitemid 34280256)
7. Biessels G. J., Staekenborg S., Brunner E., Brayne C., Scheltens P., Risk of dementia in diabetes mellitus: a systematic review. The Lancet Neurology 2006 5 1 64 74 2-s2.0-29044449855 10.1016/S1474-4422(05)70284-2 (Pubitemid 41790697)
8. Reijmer Y. D., van den Berg E., Ruis C., Kappelle L. J., Biessels G. J., Cognitive dysfunction in patients with type 2 diabetes. Diabetes-Metabolism Research and Reviews 2010 26 7 507 519 2-s2.0-78650794280 10.1002/dmrr.1112
9. Patiño-Fernández A. M., Delamater A. M., Applegate E. B., Brady E., Eidson M., Nemery R., Gonzalez-Mendoza L., Richton S., Neurocognitive functioning in preschool-age children with type 1 diabetes mellitus. Pediatric Diabetes 2010 11 6 424 430 2-s2.0-77956119993 10.1111/j.1399-5448.2009.00618.x
10. Biessels G.-J., Kamal A., Ramakers G. M., Urban I. J., Spruijt B. M., Erkelens D. W., Gispen W. H., Place learning and hippocampal synaptic plasticity in streptozotocin- induced diabetic rats. Diabetes 1996 45 9 1259 1266 2-s2.0-0029821906 (Pubitemid 26296329)
11. Van Harten B., Oosterman J., Muslimovic D., van Loon B.-J. P., Scheltens P., Weinstein H. C., Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age and Ageing 2007 36 2 164 170 2-s2.0-33947357018 10.1093/ageing/afl180 (Pubitemid 46455395)
12. Ebady S. A., Arami M. A., Shafigh M. H., Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Research and Clinical Practice 2008 82 3 305 309 2-s2.0-55549144706 10.1016/j.diabres.2008.08.020
13. Munshi M., Grande L., Hayes M., Ayres D., Suhl E., Capelson R., Lin S., Milberg W., Katie Weinger E., Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006 29 8 1794 1799 2-s2.0-33746654859 10.2337/dc06-0506 (Pubitemid 44156632)
14. Kanaya A. M., Barrett-Connor E., Gildengorin G., Yaffe K., Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo Study cohort. Archives of Internal Medicine 2004 164 12 1327 1333 2-s2.0-3042589342 10.1001/archinte.164.12.1327 (Pubitemid 38828884)
15. Maggi S., Limongi F., Noale M., Romanato G., Tonin P., Rozzini R., Scafato E., Crepaldi G., Diabetes as a risk factor for cognitive decline in older patients. Dementia and Geriatric Cognitive Disorders 2009 27 1 24 33 2-s2.0-57649101378 10.1159/000183842
16. Logroscino G., Kang J. H., Grodstein F., Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. British Medical Journal 2004 328 7439 548 551 2-s2.0-1542373533 (Pubitemid 38316623)
17. Cox D. J., Kovatchev B. P., Gonder-Frederick L. A., Summers K. H., McCall A., Grimm K. J., Clarke W. L., Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 2005 28 1 71 77 2-s2.0-11844306546 10.2337/diacare.28.1.71 (Pubitemid 40095785)
18. Xu W. L., Von Strauss E., Qiu C. X., Winblad B., Fratiglioni L., Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia 2009 52 6 1031 1039 2-s2.0-67349085203 10.1007/s00125-009-1323-x
19. Bruce D. G., Davis W. A., Casey G. P., Starkstein S. E., Clarnette R. M., Foster J. K., Almeida O. P., Davis T. M. E., Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 2008 51 2 241 248 2-s2.0-37549010373 10.1007/s00125-007-0894-7
20. Wessels A. M., Scheltens P., Barkhof F., Heine R. J., Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. European Journal of Pharmacology 2008 585 1 88 96 2-s2.0-42249104209 10.1016/j.ejphar. 2007.11.080
21. Fukui K., Omoi N.-O., Hayasaka T., Shinnkai T., Suzuki S., Abe K., Urano S., Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Annals of the New York Academy of Sciences 2002 959 275 284 2-s2.0-0036240260 (Pubitemid 34457568)
22. Comin D., Gazarini L., Zanoni J. N., Milani H., de Oliveira R. M. W., Vitamin E improves learning performance and changes the expression of nitric oxide-producing neurons in the brains of diabetic rats. Behavioural Brain Research 2010 210 1 38 45 2-s2.0-77949567130 10.1016/j.bbr.2010.02.001
23. Kuhad A., Chopra K., Effect of sesamol on diabetes-associated cognitive decline in rats. Experimental Brain Research 2008 185 3 411 420 2-s2.0-39049117924 10.1007/s00221-007-1166-y (Pubitemid 351239561)
24. Srivastava S. K., Ramana K. V., Bhatnagar A., Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocrine Reviews 2005 26 3 380 392 2-s2.0-18844369302 10.1210/er.2004-0028 (Pubitemid 40691299)
25. Malone M. A., Schocken D. D., Hanna S. K., Liang X., Malone J. I., Diabetes-induced bradycardia is an intrinsic metabolic defect reversed by carnitine. Metabolism 2007 56 8 1118 1123 2-s2.0-34347396956 10.1016/j.metabol.2007.04.005 (Pubitemid 47021178)
26. Wright E. Jr., Scism-Bacon J. L., Glass L. C., Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. International Journal of Clinical Practice 2006 60 3 308 314 2-s2.0-33644766950 10.1111/j.1368-5031. 2006.00825.x (Pubitemid 43337611)
27. Ahmad F. K., He Z., King G. L., Molecular targets of diabetic cardiovascular complications. Current Drug Targets 2005 6 4 487 494 2-s2.0-21444454887 10.2174/1389450054021990 (Pubitemid 40916273)
28. Toth C., Schmidt A. M., Tuor U. I., Francis G., Foniok T., Brussee V., Kaur J., Yan S. F., Martinez J. A., Barber P. A., Buchan A., Zochodne D. W., Diabetes, leukoencephalopathy and rage. Neurobiology of Disease 2006 23 2 445 461 2-s2.0-33746349818 10.1016/j.nbd.2006.03.015 (Pubitemid 44109669)
29. Brownlee M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 6865 813 820 2-s2.0-0035856980 10.1038/414813a (Pubitemid 34000785)
30. Ramakrishnan R., Sheeladevi R., Suthanthirarajan N., PKC- α mediated alterations of indoleamine contents in diabetic rat brain. Brain Research Bulletin 2004 64 2 189 194 2-s2.0-4444231193 10.1016/j.brainresbull. 2004.07.002 (Pubitemid 39165876)
31. Aragno M., Mastrocola R., Medana C., Restivo F., Catalano M. G., Pons N., Danni O., Boccuzzi G., Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment. Endocrinology 2005 146 12 5561 5567 2-s2.0-27844525883 10.1210/en.2005-0712 (Pubitemid 41653072)
32. Launer L. J., Miller M. E., Williamson J. D., Lazar R. M., Gerstein H. C., Murray A. M., Sullivan M., Horowitz K. R., Ding J., Marcovina S., Lovato L. C., Lovato J., Margolis K. L., O'Connor P., Lipkin E. W., Hirsch J., Coker L., Maldjian J., Sunshine J. L., Truwit C., Davatzikos C., Bryan R. N., Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. The Lancet Neurology 2011 10 11 969 977 2-s2.0-80054748660 10.1016/S1474-4422(11)70188-0
33. Friedewald W. T., Buse J. B., Bigger J. T., Byington R. P., Cushman W. C., Gerstein H. C., Ginsberg H. N., Goff D. C. Jr., Grimm R. H. Jr., Ismail-Beigi F., Probstfield J. L., Simons-Morton D. G., Effects of intensive glucose lowering in type 2 diabetes. New England Journal of Medicine 2008 358 24 2545 2559 2-s2.0-45149131667 10.1056/NEJMoa0802743 (Pubitemid 351831356)
34. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P. D., Zieve F. J., Marks J., Davis S. N., Hayward R., Warren S. R., Goldman S., McCarren M., Vitek M. E., Henderson W. G., Huang G. D., Glucose control and vascular complications in veterans with type 2 diabetes. New England Journal of Medicine 2009 360 2 129 139 2-s2.0-58149389215 10.1056/NEJMoa0808431
35. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., Marre M., Cooper M., Glasziou P., Grobbee D., Hamet P., Harrap S., Heller S., Liu L., Mancia G., Mogensen C. E., Pan C., Poulter N., Rodgers A., Williams B., Bompoint S., De Galan B. E., Joshi R., Travert F., Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine 2008 358 24 2560 2572 2-s2.0-45149133036 10.1056/NEJMoa0802987 (Pubitemid 351831357)
36. Auer R. N., Hypoglycemic brain damage. Metabolic Brain Disease 2004 19 3-4 169 175 2-s2.0-5444244399 10.1023/B:MEBR.0000043967.78763.5b (Pubitemid 39361179)
37. McAulay V., Deary I. J., Frier B. M., Symptoms of hypoglycaemia in people with diabetes. Diabetic Medicine 2001 18 9 690 705 2-s2.0-0034797567 10.1046/j.1464-5491.2001.00620.x (Pubitemid 32955520)
38. Whitmer R. A., Karter A. J., Yaffe K., Quesenberry C. P. Jr., Selby J. V., Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. Journal of the American Medical Association 2009 301 15 1565 1572 2-s2.0-64749114159 10.1001/jama.2009.460
39. Hershey T., Craft S., Bhargava N., White N. H., Memory and insulin dependent diabetes mellitus (IDDM): effects of childhood onset and severe hypoglycemia. Journal of the International Neuropsychological Society 1997 3 6 509 520 2-s2.0-0030853164 (Pubitemid 27510833)
40. Jacobson A. M., Musen G., Ryan C. M., For the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007 356 18 1842 1852
41. Brands A. M. A., Biessels G. J., De Haan E. H. F., Kappelle L. J., Kessels R. P. C., The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005 28 3 726 735 2-s2.0-14644440529 10.2337/diacare.28.3.726 (Pubitemid 40315341)
42. Bruce D. G., Davis W. A., Casey G. P., Clarnette R. M., Brown S. G. A., Jacobs I. G., Almeida O. P., Davis T. M. E., Severe hypoglycaemia and cognitive impairment in older patients with diabetes. The Fremantle Diabetes Study. Diabetologia 2009 52 9 1808 1815 2-s2.0-68449084325 10.1007/s00125-009-1437-1
43. Warren R. E., Frier B. M., Hypoglycaemia and cognitive function. Diabetes, Obesity and Metabolism 2005 7 5 493 503 2-s2.0-23844466317 10.1111/j.1463-1326.2004.00421.x (Pubitemid 41150423)
44. Biessels G. J., Hypoglycemia and dementia in type 2 diabetes: chick or egg? Nature Reviews Endocrinology 2009 5 10 532 534 2-s2.0-70349459450 10.1038/nrendo.2009.182
45. Aye T., Reiss A. L., Kesler S., Hoang S., Drobny J., Park Y., Schleifer K., Baumgartner H., Wilson D. M., Buckingham B. A., The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children. Diabetes Care 2011 34 7 1458 1462 2-s2.0-80054711388
46. Åsvold B. O., Sand T., Hestad K., Bjørgaas M. R., Cognitive function in type 1 diabetic adults with early exposure to severe hypoglycemia: a 16-year follow-up study. Diabetes Care 2010 33 9 1945 1947 2-s2.0-78650595478 10.2337/dc10-0621
47. Banks W. A., The source of cerebral insulin. European Journal of Pharmacology 2004 490 1-3 5 12 2-s2.0-1842734659 10.1016/j.ejphar.2004.02.040 (Pubitemid 38482157)
48. Gerozissis K., Brain insulin and feeding: a bi-directional communication. European Journal of Pharmacology 2004 490 1-3 59 70 2-s2.0-1842840805 10.1016/j.ejphar.2004.02.044 (Pubitemid 38488858)
49. Zhao W.-Q., Alkon D. L., Role of insulin and insulin receptor in learning and memory. Molecular and Cellular Endocrinology 2001 177 1-2 125 134 2-s2.0-0035947044 10.1016/S0303-7207(01)00455-5 (Pubitemid 32506813)
50. Steen E., Terry B. M., Rivera E. J., Cannon J. L., Neely T. R., Tavares R., Xu X. J., Wands J. R., De La Monte S. M., Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? Journal of Alzheimer's Disease 2005 7 1 63 80 2-s2.0-15244351255 (Pubitemid 40387185)
51. De La Monte S. M., Wands J. R., Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. Journal of Alzheimer's Disease 2005 7 1 45 61 2-s2.0-15244350991 (Pubitemid 40387184)
52. Young S. E., Mainous A. G. III, Carnemolla M., Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care 2006 29 12 2688 2693 2-s2.0-33845496126 10.2337/dc06-0915 (Pubitemid 44912200)
53. Bhat R. V., Shanley J., Correll M. P., Fieles W. E., Keith R. A., Scott C. W., Lee C.-M., Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3 β in cellular and animal models of neuronal degeneration. Proceedings of the National Academy of Sciences of the United States of America 2000 97 20 11074 11079 2-s2.0-0034718421
54. Phiel C. J., Wilson C. A., Lee V. M.-Y., Klein P. S., GSK-3 α regulates production of Alzheimer's disease amyloid- β peptides. Nature 2003 423 6938 435 439 2-s2.0-0038187674 10.1038/nature01640 (Pubitemid 36626994)
55. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E. A., Frosch M. P., Eckman C. B., Tanzi R. E., Selkoe D. J., Guénette S., Insulin-degrading enzyme regulates the levels of insulin, amyloid β -protein, and the β -amyloid precursor protein intracellular domain in vivo. Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 4162 4167 2-s2.0-0037390039 10.1073/pnas.0230450100 (Pubitemid 36418174)
56. Qiu W. Q., Walsh D. M., Ye Z., Vekrellis K., Zhang J., Podlisny M. B., Rosner M. R., Safavi A., Hersh L. B., Selkoe D. J., Insulin-degrading enzyme regulates extracellular levels of amyloid β -protein by degradation. Journal of Biological Chemistry 1998 273 49 32730 32738 2-s2.0-0000398342 10.1074/jbc.273.49.32730 (Pubitemid 28557658)
57. Elias P. K., Elias M. F., D'Agostino R. B., Cupples L. A., Wilson P. W., Silbershatz H., Wolf P. A., NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 1997 20 9 1388 1395 2-s2.0-0030873815 (Pubitemid 27366813)
58. Van Den Berg E., Dekker J. M., Nijpels G., Kessels R. P. C., Kappelle L. J., De Haan E. H. F., Heine R. J., Stehouwer C. D. A., Biessels G. J., Blood pressure levels in pre-diabetic stages are associated with worse cognitive functioning in patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews 2009 25 7 657 664 2-s2.0-70350614142 10.1002/dmrr.1009
59. Bruehl H., Wolf O. T., Sweat V., Tirsi A., Richardson S., Convit A., Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Research 2009 1280 186 194 2-s2.0-67649421600 10.1016/j.brainres.2009.05.032
60. Manschot S. M., Biessels G. J., De Valk H., Algra A., Rutten G. E. H. M., Van Der Grond J., Kappelle L. J., Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 2007 50 11 2388 2397 2-s2.0-34848835838 10.1007/s00125-007-0792-z (Pubitemid 47512398)
61. Ruitenberg A., Skoog I., Ott A., Aevarsson O., Witteman J. C. M., Lernfelt B., Van Harskamp F., Hofman A., Breteler M. M. B., Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 study. Dementia and Geriatric Cognitive Disorders 2001 12 1 33 39 2-s2.0-0035183839 10.1159/000051233 (Pubitemid 32008939)
62. Mielke M. M., Zandi P. P., Sjögren M., Gustafson D., Östling S., Steen B., Skoog I., High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 2005 64 10 1689 1695 2-s2.0-18844457544 10.1212/01.WNL.0000161870.78572.A5 (Pubitemid 40695799)
63. Kloppenborg R. P., van den Berg E., Kappelle L. J., Biessels G. J., Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. European Journal of Pharmacology 2008 585 1 97 108 2-s2.0-42249089508 10.1016/j.ejphar.2008.02.049
64. Luchsinger J. A., Tang M.-X., Stern Y., Shea S., Mayeux R., Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. American Journal of Epidemiology 2001 154 7 635 641 2-s2.0-0035479310 10.1093/aje/154.7.635 (Pubitemid 32888781)
65. Alter M., Lai S.-M., Friday G., Singh V., Mangesh Kumar V., Sobel E., Stroke recurrence in diabetics: does control of blood glucose reduce risk? Stroke 1997 28 6 1153 1157 2-s2.0-0031000451 (Pubitemid 27248887)
66. Rodriguez G., Nobili F., Celestino M. A., Francione S., Gulli G., Hassan K., Marenco S., Rosadini G., Cordera R., Regional cerebral blood flow and cerebrovascular reactivity in IDDM. Diabetes Care 1993 16 2 462 468 2-s2.0-0027513346 (Pubitemid 23046637)
67. Johnson P. C., Brendel K., Meezan E., Thickened cerebral cortical capillary basement membranes in diabetes. Archives of Pathology and Laboratory Medicine 1982 106 5 214 217 2-s2.0-0020027766 (Pubitemid 12107689)
68. Yngen M., Östenson C.-G., Hu H., Li N., Hjemdahl P., Wallén N. H., Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologia 2004 47 3 537 540 2-s2.0-1842844422 10.1007/s00125-004-1352-4 (Pubitemid 38491251)
69. Dalla Vestra M., Mussap M., Gallina P., Bruseghin M., Cernigoi A. M., Saller A., Plebani M., Fioretto P., Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. Journal of the American Society of Nephrology 2005 16 3 S78 S82 2-s2.0-20844458389 10.1681/ASN. 2004110961 (Pubitemid 41725090)
70. Schram M. T., Chaturvedi N., Schalkwijk C. G., Fuller J. H., Stehouwer C. D. A., Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes-the EURODIAB Prospective Complications Study. Diabetologia 2005 48 2 370 378 2-s2.0-17444405235 10.1007/s00125-004-1628-8 (Pubitemid 40543311)
71. Reagan L. P., Grillo C. A., Piroli G. G., The As and Ds of stress: metabolic, morphological and behavioral consequences. European Journal of Pharmacology 2008 585 1 64 75 2-s2.0-42249099439 10.1016/j.ejphar.2008.02.050
72. Stranahan A. M., Arumugam T. V., Cutler R. G., Lee K., Egan J. M., Mattson M. P., Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nature Neuroscience 2008 11 3 309 317 2-s2.0-39749137437 10.1038/nn2055 (Pubitemid 351311802)
73. Wright R. L., Lightner E. N., Harman J. S., Meijer O. C., Conrad C. D., Attenuating corticosterone levels on the day of memory assessment prevents chronic stress-induced impairments in spatial memory. European Journal of Neuroscience 2006 24 2 595 605 2-s2.0-33746210780 10.1111/j.1460-9568.2006. 04948.x (Pubitemid 44100351)
74. Tojo C., Takao T., Nishioka T., Numata Y., Suemaru S., Hashimoto K., Hypothalamic-pituitary-adrenal axis in WBN/Kob rats with non-insulin dependent diabetes mellitus. Endocrine Journal 1996 43 2 233 239 2-s2.0-0029905403 (Pubitemid 26161634)
75. Alfarez D. N., Joëls M., Krugers H. J., Chronic unpredictable stress impairs long-term potentiation in rat hippocampal CA1 area and dentate gyrus in vitro. European Journal of Neuroscience 2003 17 9 1928 1934 2-s2.0-0038054209 10.1046/j.1460-9568.2003.02622.x (Pubitemid 36645342)
76. Korz V., Frey J. U., Stress-related modulation of hippocampal long-term potentiation in rats: involvement of adrenal steroid receptors. Journal of Neuroscience 2003 23 19 7281 7287 2-s2.0-0041737641 (Pubitemid 36999517)
77. Revsin Y., Rekers N. V., Louwe M. C., Saravia F. E., De Nicola A. F., De Kloet E. R., Oitzl M. S., Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuropsychopharmacology 2009 34 3 747 758 2-s2.0-58149468794 10.1038/npp.2008.136
78. Messier C., Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiology of Aging 2005 26, supplement S26 S30 2-s2.0-28444433338 10.1016/j.neurobiolaging.2005.09.014 (Pubitemid 41739421)
79. Desrocher M., Rovet J., Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychology 2004 10 1 36 52 2-s2.0-1842507154 10.1076/chin.10.1.36.26241 (Pubitemid 38418932)
80. Sandeep T. C., Yau J. L. W., MacLullich A. M. J., Noble J., Deary I. J., Walker B. R., Seckl J. R., 11 β -hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proceedings of the National Academy of Sciences of the United States of America 2004 101 17 6734 6739 2-s2.0-2342616297 10.1073/pnas.0306996101 (Pubitemid 38586043)
81. Lupien S. J., Maheu F., Tu M., Fiocco A., Schramek T. E., The effects of stress and stress hormones on human cognition: implications for the field of brain and cognition. Brain and Cognition 2007 65 3 209 237 2-s2.0-35748961429 10.1016/j.bandc.2007.02.007 (Pubitemid 350051538)
82. Anderson R. J., Freedland K. E., Clouse R. E., Lustman P. J., The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001 24 6 1069 1078 2-s2.0-0035374580 (Pubitemid 33716379)
83. Everson S. A., Maty S. C., Lynch J. W., Kaplan G. A., Epidemiologic evidence on the comorbidity of depression and diabetes. Journal of Psychosomatic Research 2002 53 4 903 906 2-s2.0-0036805294 10.1016/S0022-3999(02)00302-1 (Pubitemid 35282620)
84. Knol M. J., Twisk J. W. R., Beekman A. T. F., Heine R. J., Snoek F. J., Pouwer F., Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006 49 5 837 845 2-s2.0-33646423317 10.1007/s00125-006-0159-x
85. Dufouil C., Fuhrer R., Dartigues J.-F., Alpérovitch A., Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration. American Journal of Epidemiology 1996 144 7 634 641 2-s2.0-0029743350 (Pubitemid 26322514)
86. Lambert G. W., Schlaich M. P., Esler M. D., Brain derived neurotrophic factor (BDNF) release from the human brain in patients with type 2 diabetes-Possible influence of venous anatomy and comorbid major depressive disorder. Diabetologia 2007 50 9 2027 2028 2-s2.0-34547685574 10.1007/s00125-007-0756-3 (Pubitemid 47222868)
87. Bruce D. G., Casey G., Davis W. A., Starkstein S. E., Clarnette R. C., Foster J. K., Ives F. J., Almeida O. P., Davis T. M. E., Vascular depression in older people with diabetes. Diabetologia 2006 49 12 2828 2836 2-s2.0-33750926076 10.1007/s00125-006-0478-y (Pubitemid 44730284)
88. Lyoo I. K., Yoon S. J., Musen G., Simonson D. C., Weinger K., Bolo N., Ryan C. M., Kim J. E., Renshaw P. F., Jacobson A. M., Altered prefrontal glutamate-glutamine- γ -aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. Archives of General Psychiatry 2009 66 8 878 887 2-s2.0-68149180517 10.1001/archgenpsychiatry.2009.86
89. Northam E. A., Rankins D., Lin A., Wellard R. M., Pell G. S., Finch S. J., Werther G. A., Cameron F. J., Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2009 32 3 445 450 2-s2.0-64749088646 10.2337/dc08-1657
90. Kuhad A., Sethi R., Chopra K., Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sciences 2008 83 3-4 128 134 2-s2.0-46449094796 10.1016/j.lfs.2008.05.013
91. Schmatz R., Mazzanti C. M., Spanevello R., Stefanello N., Gutierres J., Corrêa M., da Rosa M. M., Rubin M. A., Chitolina Schetinger M. R., Morsch V. M., Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. European Journal of Pharmacology 2009 610 1-3 42 48 2-s2.0-65049090141 10.1016/j.ejphar.2009.03.032
92. Sánchez-Chávez G., Salceda R., Effect of streptozotocin-induced diabetes on activities of cholinesterases in the rat retina. IUBMB Life 2000 49 4 283 287 2-s2.0-0343962228 (Pubitemid 30421854)
93. Kamal A., Biessels G.-J., Urban I. J. A., Gispen W. H., Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience 1999 90 3 737 745 2-s2.0-0032893770 10.1016/S0306-4522(98)00485-0 (Pubitemid 29156740)
94. Valastro B., Cossette J., Lavoie N., Gagnon S., Trudeau F., Massicotte G., Up-regulation of glutamate receptors is associated with LTP defects in the early stages of diabetes mellitus. Diabetologia 2002 45 5 642 650 2-s2.0-0035985080 10.1007/s00125-002-0818-5 (Pubitemid 34810688)
95. Wang T., Fu F., Han B., Zhang L., Zhang X., Danshensu ameliorates the cognitive decline in streptozotocin-induced diabetic mice by attenuating advanced glycation end product-mediated neuroinflammation. Journal of Neuroimmunology 2012 245 1-2 79 86 2-s2.0-84859635287 10.1016/j.jneuroim.2012. 02.008
96. Liu Y.-W., Zhu X., Lu Q., Wang J.-Y., Li W., Wei Y.-Q., Yin X.-X., Total saponins from Rhizoma Anemarrhenae ameliorate diabetes-associated cognitive decline in rats: involvement of amyloid-beta decrease in brain. Journal of Ethnopharmacology 2012 139 1 194 200 2-s2.0-83555173614 10.1016/j.jep.2011.11. 004
97. Fukuhara M., Matsumura K., Wakisaka M., Takata Y., Sonoki K., Fujisawa K., Ansai T., Akifusa S., Fujii K., Iida M., Takehara T., Hyperglycemia promotes microinflammation as evaluated by C-reactive protein in the very elderly. Internal Medicine 2007 46 5 207 212 2-s2.0-33947149182 10.2169/internalmedicine. 46.1868 (Pubitemid 46403661)
98. Kowluru R. A., Kanwar M., Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutrition and Metabolism 2007 4, article 8 2-s2.0-34247542013 10.1186/1743-7075-4-8 (Pubitemid 46663082)
99. Liu Y.-W., Zhu X., Li W., Lu Q., Wang J.-Y., Wei Y.-Q., Yin X.-X., Ginsenoside Re attenuates diabetes-associated cognitive deficits in rats. Pharmacology Biochemistry and Behavior 2012 101 1 93 98 2-s2.0-84855782104 10.1016/j.pbb.2011.12.003
100. Bhutada P., Mundhada Y., Bansod K., Tawari S., Patil S., Dixit P., Umathe S., Mundhada D., Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behavioural Brain Research 2011 220 1 30 41 2-s2.0-79952758240 10.1016/j.bbr.2011.01.022
101. Kuhad A., Chopra K., Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. European Journal of Pharmacology 2007 576 1-3 34 42 2-s2.0-35348851411 10.1016/j.ejphar.2007.08.001 (Pubitemid 47588254)
102. Parihar M. S., Chaudhary M., Shetty R., Hemnani T., Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. Journal of Clinical Neuroscience 2004 11 4 397 402 2-s2.0-2342512006 10.1016/j.jocn.2003. 09.008 (Pubitemid 38568479)
103. Artola A., Diabetes-, stress- and ageing-related changes in synaptic plasticity in hippocampus and neocortex-the same metaplastic process? European Journal of Pharmacology 2008 585 1 153 162 2-s2.0-42449124483 10.1016/j.ejphar.2007.11.084
104. Reisi P., Babri S., Alaei H., Sharifi M. R., Mohaddes G., Lashgari R., Effects of treadmill running on short-term pre-synaptic plasticity at dentate gyrus of streptozotocin-induced diabetic rats. Brain Research 2008 1211 30 36 2-s2.0-43049174998 10.1016/j.brainres.2008.03.024
105. Ye L., Wang F., Yang R.-H., Diabetes impairs learning performance and affects the mitochondrial function of hippocampal pyramidal neurons. Brain Research 2011 1411 57 64 2-s2.0-80052021917 10.1016/j.brainres.2011.07.011
106. Kalalian-Moghaddam H., Baluchnejadmojarad T., Roghani M., Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin- diabetic rats. European Journal of Pharmacology 2013 698 259 266
107. Van Den Berg E., Reijmer Y. D., De Bresser J., Kessels R. P. C., Kappelle L. J., Biessels G. J., A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 2010 53 1 58 65 2-s2.0-72449143567 10.1007/s00125-009-1571-9
108. Kuusisto J., Koivisto K., Mykkänen L., Helkala E.-L., Vanhanen M., Hänninen T., Kervinen K., Kesäniemi Y. A., Riekkinen P. J., Laakso M., Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. British Medical Journal 1997 315 7115 1045 1049 2-s2.0-9844229370 (Pubitemid 27458392)